Pfam 26.0 - JenaLib Tree Browser

Family: Flavi_NS5 (21)

Dengue virus 2 (5)

2P3Q	A:251-264	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH GPPPG AND S-ADENOSYL-L-HOMOCYSTEINE
2P3L	A:251-264	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH GPPPA AND S-ADENOSYL-L-HOMOCYSTEINE
2P3O	A:251-264	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH 7MEGPPPA AND S-ADENOSYL-L-HOMOCYSTEINE
2P40	A:251-269	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH 7MEGPPPG
2P41	A:251-264	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH 7MEGPPPG2'OME AND S-ADENOSYL-L-HOMOCYSTEINE

Dengue virus 3 (3)

2XBM	D:250-263; D:250-263; D:250-263; D:250-263	CRYSTAL STRUCTURE OF THE DENGUE VIRUS METHYLTRANSFERASE BOUND TO A 5'-CAPPED OCTAMERIC RNA
3P8Z	C:250-262; C:250-262	DENGUE METHYLTRANSFERASE BOUND TO A SAM-BASED INHIBITOR
3P97	C:250-262; C:250-262	DENGUE 3 NS5 METHYLTRANSFERASE BOUND TO THE SUBSTRATE S-ADENOSYL METHIONINE

Dengue virus type 2 (strain Puerto Rico/PR159-S1/1969) (DENV-2) (3)

1L9K	A:251-267	DENGUE METHYLTRANSFERASE
1R6A	A:251-268	STRUCTURE OF THE DENGUE VIRUS 2'O METHYLTRANSFERASE IN COMPLEX WITH S-ADENOSYL HOMOCYSTEINE AND RIBAVIRIN 5' TRIPHOSPHATE
2P1D	A:251-265	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH GTP AND S-ADENOSYL-L-HOMOCYSTEINE

Meaban virus (1)

2OXT

D:253-265; D:253-265; D:253-265; D:253-265

CRYSTAL STRUCTURE OF MEABAN VIRUS NUCLEOSIDE-2'-O-METHYLTRANSFERASE

Modoc virus (2)

2WA1	B:253-267	STRUCTURE OF THE METHYLTRANSFERASE DOMAIN FROM MODOC VIRUS, A FLAVIVIRUS WITH NO KNOWN VECTOR (NKV)
2WA2	B:253-266	STRUCTURE OF THE METHYLTRANSFERASE DOMAIN FROM MODOC VIRUS, A FLAVIVIRUS WITH NO KNOWN VECTOR (NKV)

Murray valley encephalitis virus (strain MVE-1-51) (MVEV) (6)

2PX2	B:253-267; B:253-267	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (MONOCLINIC FORM 1)
2PX4	A:253-268	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (MONOCLINIC FORM 2)
2PX5	B:253-267; B:253-267	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (ORTHORHOMBIC CRYSTAL FORM)
2PX8	B:253-269; B:253-269	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH AND 7M-GTP
2PXA	B:253-267; B:253-267	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH AND GTPG
2PXC	A:253-267	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAM AND GTPA

West Nile virus (WNV) (1)

2OY0

B:253-267; B:253-267

CRYSTAL STRUCTURE OF THE WEST NILE VIRUS METHYLTRANSFERASE

Family: RVT_1 (95)

Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1) (27)

1N5Y	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
1N6Q	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
1QE1	B:63-234; B:63-234	CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
1R0A	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
1S6P	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943
1S6Q	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681
1S9E	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385
1S9G	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394.
1SUQ	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545
1SV5	B:63-234; B:63-234	CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335
1T03	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
1T05	A:63-234	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE
1TV6	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707
1TVR	B:63-234; B:63-234	HIV-1 RT/9-CL TIBO
1UWB	B:63-234; B:63-234	TYR 181 CYS HIV-1 RT/8-CL TIBO
2VG5	B:1063-1234; B:1063-1234	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
2VG6	B:1063-1234; B:1063-1234	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
2VG7	B:1063-1234; B:1063-1234	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
2ZD1	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
2ZE2	B:63-234; B:63-234	CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR
3JYT	B:63-234; B:63-234	K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH DATP AS THE INCOMING NUCLEOTIDE SUBSTRATE
3KLE	N:63-234; N:63-234; N:63-234; N:63-234; N:63-234; N:63-234; N:63-234; N:63-234	CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT, AZTPPPPA
3KLF	N:63-234; N:63-234; N:63-234; N:63-234; N:63-234; N:63-234; N:63-234; N:63-234	CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT, AZTPPPPA
3KLG	F:63-234; F:63-234; F:63-234; F:63-234	CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
3KLH	B:63-234; B:63-234	CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
3KLI	B:63-234; B:63-234	CRYSTAL STRUCTURE OF UNLIGANDED AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE
3QO9	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TSAO-T, A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)

Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) (HIV-1) (57)

1JKH	B:63-234; B:63-234	CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
1JLA	B:63-234; B:63-234	CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
1JLB	B:63-234; B:63-234	CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1JLE	B:63-234; B:63-234	CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE
1JLG	B:63-234; B:63-234	CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
1JLQ	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94
1KLM	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152
1LW0	B:63-234; B:63-234	CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1LW2	B:63-234; B:63-234	CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91
1LWC	B:63-234; B:63-234	CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1LWE	B:63-234; B:63-234	CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE
1LWF	B:63-234; B:63-234	CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE
1REV	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE
1RT1	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442
1RT2	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651
1RT3	B:63-234; B:63-234	AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91
1RT5	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10
1RT6	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38
1RT7	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84
1RTH	B:63-234; B:63-234	HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES
1RTJ	B:63-234; B:63-234	MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS
1S1T	B:63-234; B:63-234	CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
1S1U	B:63-234; B:63-234	CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1S1W	B:63-234; B:63-234	CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
1S1X	B:63-234; B:63-234	CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
1T05	B:63-234	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE
1TKT	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318
1TKX	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745
1TL1	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211
1TL3	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557
1VRU	B:63-234; B:63-234	HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT-INHIBITOR COMPLEXES
2OPP	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
2OPQ	B:63-234; B:63-234	CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
2OPR	B:63-234; B:63-234	CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
2OPS	B:63-234; B:63-234	CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
2RF2	B:63-234; B:63-234	HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI)
2RKI	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI
2WOM	B:63-234; B:63-234	CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N).
2WON	B:63-234; B:63-234	CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE).
3KJV	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA
3KK1	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS-9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE
3KK2	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE
3KK3	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER
3LAK	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-HETEROCYCLE PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
3LAL	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-ETHYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
3LAM	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-PROPYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
3LAN	B:63-234; B:63-234	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-BUTYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
3LP0	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
3LP1	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
3LP2	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
3M8P	B:63-234; B:63-234	HIV-1 RT WITH NNRTI TMC-125
3MEC	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
3MED	B:63-234; B:63-234	HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
3MEE	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
3MEG	B:63-234; B:63-234	HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
3NBP	B:63-234; B:63-234	HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2
3QIP	B:63-234; B:63-234	STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH AN RNASE H INHIBITOR AND NEVIRAPINE

Human immunodeficiency virus type 2 subtype A (isolate ROD) (HIV-2) (1)

1MU2

B:63-234; B:63-234

CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE

Moloney murine leukemia virus (isolate Shinnick) (MoMLV) (10)

1MML	A:101-273	MECHANISTIC IMPLICATIONS FROM THE STRUCTURE OF A CATALYTIC FRAGMENT OF MMLV REVERSE TRANSCRIPTASE
1N4L	A:101-273	A DNA ANALOGUE OF THE POLYPURINE TRACT OF HIV-1
1QAI	B:101-273; B:101-273	CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN
1QAJ	B:101-273; B:101-273	CRYSTAL STRUCTURES OF THE N-TERMINAL FRAGMENT FROM MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE COMPLEXED WITH NUCLEIC ACID: FUNCTIONAL IMPLICATIONS FOR TEMPLATE-PRIMER BINDING TO THE FINGERS DOMAIN
1ZTT	A:101-273	NETROPSIN BOUND TO D(CTTAATTCGAATTAAG) IN COMPLEX WITH MMLV RT CATALYTIC FRAGMENT
1ZTW	A:101-273	D(CTTAATTCGAATTAAG) COMPLEXED WITH MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE CATALYTIC FRAGMENT
2R2R	A:101-273	D(ATTAGTTATAACTAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT
2R2S	A:101-273	CO(III)BLEOMYCINB2 BOUND TO D(ATTAGTTATAACTAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT
2R2T	A:101-273	D(ATTTAGTTAACTAAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT
2R2U	A:101-273	CO(III)BLEOMYCINB2 BITHIAZOLE/C-TERMINAL TAIL DOMAIN BOUND TO D(ATTTAGTTAACTAAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT

Tribolium castaneum (Red flour beetle) (1)

3KYL

A:187-376

STRUCTURE OF THE CATALYTIC SUBUNIT OF TELOMERASE BOUND TO ITS RNA TEMPLATE AND TELOMERIC DNA

Family: RdRP_1 (44)

Foot-and-mouth disease virus - type C (9)

3KLV	A:13-465	M296I G62S MUTANT OF FOOT-AND-MOUTH DISEASE VIRUS RNA-POLYMERASE IN COMPLEX WITH A TEMPLATE- PRIMER RNA
3KMQ	A:13-465	G62S MUTANT OF FOOT-AND-MOUTH DISEASE VIRUS RNA-POLYMERASE IN COMPLEX WITH A TEMPLATE- PRIMER RNA, TETRAGONAL STRUCTURE
3KMS	A:13-465	G62S MUTANT OF FOOT-AND-MOUTH DISEASE VIRUS RNA-POLYMERASE IN COMPLEX WITH A TEMPLATE- PRIMER RNA TRIGONAL STRUCTURE
3KNA	A:13-465	M296I MUTANT OF FOOT-AND-MOUTH DISEASE VIRUS RNA-POLYMERASE IN COMPLEX WITH A TEMPLATE- PRIMER RNA
3KOA	A:13-465	M296I MUTANT OF FOOT-AND-MOUTH DISEASE VIRUS RNA-POLYMERASE IN COMPLEX WITH A TEMPLATE- PRIMER RNA AND GTP
1U09	A:13-465	FOOTAND MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE
1WNE	A:13-465	FOOT AND MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH A TEMPLATE-PRIMER RNA
3NKY	A:13-465	STRUCTURE OF A MUTANT P44S OF FOOT-AND-MOUTH DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE
3NMA	A:13-465	MUTANT P169S OF FOOT-AND-MOUTH DISEASE VIRUS RNA DEPENDENT RNA-POLYMERASE

Human enterovirus 71 (3)

3N6L	A:17-461	THE CRYSTAL STRUCUTRE OF RNA-DEPENDENT RNA POLYMERASE OF EV71 VIRUS
3N6M	A:17-461	CRYSTAL STRUCTURE OF EV71 RDRP IN COMPLEX WITH GTP
3N6N	A:17-461	CRYSTAL STRUCTURE OF EV71 RDRP IN COMPLEX WITH BR-UTP

Human poliovirus 1 (6)

3OL6	M:17-460; M:17-460; M:17-460; M:17-460	POLIOVIRUS POLYMERASE ELONGATION COMPLEX
3OL7	M:17-460; M:17-460; M:17-460; M:17-460	POLIOVIRUS POLYMERASE ELONGATION COMPLEX WITH CTP
3OL8	M:17-460; M:17-460; M:17-460; M:17-460	POLIOVIRUS POLYMERASE ELONGATION COMPLEX WITH CTP-MN
3OL9	M:17-460; M:17-460; M:17-460; M:17-460	POLIOVIRUS POLYMERASE ELONGATION COMPLEX WITH 3'-DEOXY-CTP
3OLA	M:17-460; M:17-460; M:17-460; M:17-460	POLIOVIRUS POLYMERASE ELONGATION COMPLEX WITH 2'-DEOXY-CTP
3OLB	M:17-460; M:17-460; M:17-460; M:17-460	POLIOVIRUS POLYMERASE ELONGATION COMPLEX WITH 2',3'-DIDEOXY-CTP

Human rhinovirus 14 (HRV-14) (1)

1XR5

A:17-459

CRYSTAL STRUCTURE OF THE RNA-DEPENDENT RNA POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 14

Human rhinovirus 16 (HRV-16) (1)

1XR7

B:17-459; B:17-459

CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 16

Human rhinovirus 1B (HRV-1B) (1)

1XR6

A:17-459

CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE 3D FROM HUMAN RHINOVIRUS SEROTYPE 1B

Murine norovirus 1 (2)

3NAH	C:24-490; C:24-490; C:24-490	CRYSTAL STRUCTURES AND FUNCTIONAL ANALYSIS OF MURINE NOROVIRUS RNA-DEPENDENT RNA POLYMERASE
3NAI	C:24-490; C:24-490; C:24-490	CRYSTAL STRUCTURES AND FUNCTIONAL ANALYSIS OF MURINE NOROVIRUS RNA-DEPENDENT RNA POLYMERASE

Norwalk virus (3)

1SH0	B:20-492; B:20-492	CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (TRICLINIC)
1SH2	A:20-492	CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (METAL-FREE, CENTERED ORTHORHOMBIC)
1SH3	B:20-492; B:20-492	CRYSTAL STRUCTURE OF NORWALK VIRUS POLYMERASE (MGSO4 CRYSTAL FORM)

Poliovirus type 1 (strain Mahoney) (5)

1RA6	A:17-460	POLIOVIRUS POLYMERASE FULL LENGTH APO STRUCTURE
1RA7	A:17-460	POLIOVIRUS POLYMERASE WITH GTP
1RAJ	A:70-460	POLIOVIRUS POLYMERASE WITH A 68 RESIDUE N-TERMINAL TRUNCATION
1RDR	A:17-460	POLIOVIRUS 3D POLYMERASE
1TQL	A:17-460	POLIOVIRUS POLYMERASE G1A MUTANT

Pseudomonas phage phi6 (Bacteriophage phi-6) (8)

1UVI	C:20-637; C:20-637; C:20-637	THE STRUCTURAL BASIS FOR RNA SPECIFICITY AND CA2 INHIBITION OF AN RNA-DEPENDENT RNA POLYMERASE PHI6P2 WITH 6NT RNA
1UVK	E:20-637; E:20-637; E:20-637	THE STRUCTURAL BASIS FOR RNA SPECIFICITY AND CA2 INHIBITION OF AN RNA-DEPENDENT RNA POLYMERASE PHI6P2 DEAD-END COMPLEX
1UVL	E:20-637; E:20-637; E:20-637	THE STRUCTURAL BASIS FOR RNA SPECIFICITY AND CA2 INHIBITION OF AN RNA-DEPENDENT RNA POLYMERASE PHI6P2 WITH 5NT RNA CONFORMATION B
1UVM	C:20-637; C:20-637; C:20-637	THE STRUCTURAL BASIS FOR RNA SPECIFICITY AND CA2 INHIBITION OF AN RNA-DEPENDENT RNA POLYMERASE PHI6P2 WITH 5NT RNA CONFORMATION A
1UVN	E:20-637; E:20-637; E:20-637	THE STRUCTURAL BASIS FOR RNA SPECIFICITY AND CA2 INHIBITION OF AN RNA-DEPENDENT RNA POLYMERASE PHI6P2 CA2+ INHIBITION COMPLEX
1WAC	C:20-635; C:20-635; C:20-635	BACK-PRIMING MODE OF PHI6 RNA-DEPENDENT RNA POLYMERASE
2JLF	C:20-637; C:20-637; C:20-637	STRUCTURAL EXPLANATION FOR THE ROLE OF MN IN THE ACTIVITY OF PHI6 RNA-DEPENDENT RNA POLYMERASE
2JLG	C:20-637; C:20-637; C:20-637	STRUCTURAL EXPLANATION FOR THE ROLE OF MN IN THE ACTIVITY OF PHI6 RNA-DEPENDENT RNA POLYMERASE

Rabbit hemorrhagic disease virus (strain Rabbit/Germany/FRG/1989) (Ra/LV/RHDV/GH/1989/GE) (RHDV-FRG) (2)

1KHV	B:29-501; B:29-501	CRYSTAL STRUCTURE OF RABBIT HEMORRHAGIC DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE COMPLEXED WITH LU3+
1KHW	B:29-501; B:29-501	CRYSTAL STRUCTURE OF RABBIT HEMORRHAGIC DISEASE VIRUS RNA-DEPENDENT RNA POLYMERASE COMPLEXED WITH MN2+

Sapporo virus (strain Human/United Kingdom/Manchester/1993) (Hu/SV/Man/1993/UK) (3)

2UUT	A:19-484	THE 2.4 ANGSTROM RESOLUTION STRUCTURE OF THE D346G MUTANT OF THE SAPPORO VIRUS RDRP POLYMERASE
2UUW	A:19-490	2.75 ANGSTROM STRUCTURE OF THE D347G D348G MUTANT STRUCTURE OF SAPPORO VIRUS RDRP POLYMERASE
2WK4	B:19-490; B:19-490	DIMERIC STRUCTURE OF D347G D348G MUTANT OF THE SAPPOROVIRUS RNA DEPENDENT RNA POLYMERASE

Family: RdRP_3 (43)

Bovine viral diarrhea virus (isolate NADL) (BVDV) (Mucosal disease virus) (3)

1S48	A:229-567	CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE CONSTRUCT 1 (RESIDUES 71-679) FROM BVDV
1S49	A:229-567	CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE CONSTRUCT 1 (RESIDUES 71-679) FROM BOVINE VIRAL DIARRHEA VIRUS COMPLEXED WITH GTP
1S4F	D:229-567; D:229-567; D:229-567; D:229-567	CRYSTAL STRUCTURE OF RNA-DEPENDENT RNA POLYMERASE CONSTRUCT 2 FROM BOVINE VIRAL DIARRHEA VIRUS (BVDV)

Hepatitis C virus (7)

3QGH	A:3-514	CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE GENOTYPE 1A COMPLEX WITH N-CYCLOPROPYL-6-[(3R)-3-{[4-(TRIFLUOROMETHOXY)BENZYL]CARBAMOYL}-4-{[4-(TRIFLUOROMETHOXY) PHENYL]SULFONYL}PIPERAZIN-1-YL]PYRIDAZINE-3-CARBOXAMIDE
3QGI	A:3-514	CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE GENOTYPE 1A COMPLEX WITH N-[(2S)-BUTAN-2-YL]-6-[(3R)-3-{[4-(TRIFLUOROMETHOXY)BENZYL]CARBAMOYL}-4-{[4-(TRIFLUOROMETHOXY) PHENYL]SULFONYL}PIPERAZIN-1-YL]PYRIDAZINE-3-CARBOXAMIDE
3PHE	D:3-514; D:3-514; D:3-514; D:3-514	HCV NS5B WITH A BOUND QUINOLONE INHIBITOR
2JC0	B:3-514; B:3-514	CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB655264
2JC1	B:3-514; B:3-514	CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB698223
1YVF	A:3-514	HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH INHIBITOR PHA-00729145
1Z4U	A:3-514	HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH INHIBITOR PHA-00799585

Hepatitis C virus genotype 1a (isolate H) (HCV) (2)

2XI2	C:3-514; C:3-514; C:3-514	HCV-H77 NS5B APO POLYMERASE
2XI3	B:3-514; B:3-514	HCV-H77 NS5B POLYMERASE COMPLEXED WITH GTP

Hepatitis C virus genotype 1b (isolate BK) (HCV) (10)

1NHU	B:3-514; B:3-514	HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE ANALOGUE INHIBITOR
1NHV	B:3-514; B:3-514	HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE ANALOGUE INHIBITOR
1OS5	A:3-514	CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE COMPLEXED WITH A NOVEL NON-COMPETITIVE INHIBITOR.
1QUV	A:3-514	CRYSTAL STRUCTURE OF THE RNA DIRECTED RNA POLYMERASE OF HEPATITIS C VIRUS
2O5D	B:3-514; B:3-514	THIAZOLONE-ACYLSULFONAMIDES AS NOVEL HCV NS5B POLYMERASE ALLOSTERIC INHIBITORS: CONVERGENCE OF STRUCTURE-BASED DRUG DESIGN AND X-RAY CRYSTALLOGRAPHIC STUDY
2WCX	A:3-514	CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS5B POLYMERASE IN COMPLEX WITH THIENOPYRROLE-BASED FINGER-LOOP INHIBITORS
2WHO	B:3-514; B:3-514	CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS5B POLYMERASE FROM 1B GENOTYPE IN COMPLEX WITH A NON-NUCLEOSIDE INHIBITOR
2WRM	A:3-514	IDENTIFICATION OF NOVEL ALLOSTERIC INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE THUMB DOMAIN (SITE II) BY STRUCTURE-BASED DESIGN
2ZKU	D:3-514; D:3-514; D:3-514; D:3-514	STRUCTURE OF HEPATITIS C VIRUS NS5B POLYMERASE IN A NEW CRYSTAL FORM
3MF5	B:3-514; B:3-514	HEPATITIS C VIRUS POLYMERASE NS5B (BK) WITH AMIDE BIOISOSTERE THUMB SITE INHIBITOR

Hepatitis C virus genotype 1b (isolate Con1) (HCV) (5)

3Q0Z	B:3-514; B:3-514	CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH (2E)-3-(4-{[(1-{[(13-CYCLOHEXYL-6-OXO-6,7-DIHYDRO-5H-INDOLO[1,2-D][1,4]BENZODIAZEPIN-10-YL) CARBONYL]AMINO}CYCLOPENTYL)CARBONYL]AMINO}PHENYL)PROP-2-ENOIC ACID
3QGD	B:3-514; B:3-514	CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH (2E)-3-(4-{[(1-{[(13-CYCLOHEXYL-6-OXO-6,7-DIHYDRO-5H-INDOLO[1,2-D][1,4]BENZODIAZEPIN-10-YL) CARBONYL]AMINO}CYCLOPENTYL)CARBONYL]AMINO}PHENYL)PROP-2-ENOIC ACID AND (2R)-4-(2,6-DIMETHOXYPYRIMIDIN-4-YL)-1-[(4-ETHYLPHENYL)SULFONYL]-N-(4-METHOXYBENZYL)PIPERAZINE-2-CARBOXAMIDE
3QGE	B:3-514; B:3-514	CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH (2E)-3-(4-{[(1-{[(13-CYCLOHEXYL-6-OXO-6,7-DIHYDRO-5H-INDOLO[1,2-D][1,4]BENZODIAZEPIN-10-YL) CARBONYL]AMINO}CYCLOPENTYL)CARBONYL]AMINO}PHENYL)PROP-2-ENOIC ACID AND (2R)-4-(2,6-DIMETHOXYPYRIMIDIN-4-YL)-N-(4-METHOXYBENZYL)-1-{[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}PIPERAZINE-2-CARBOXAMIDE
3QGF	B:3-514; B:3-514	CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH (2E)-3-(4-{[(1-{[(13-CYCLOHEXYL-6-OXO-6,7-DIHYDRO-5H-INDOLO[1,2-D][1,4]BENZODIAZEPIN-10-YL) CARBONYL]AMINO}CYCLOPENTYL)CARBONYL]AMINO}PHENYL)PROP-2-ENOIC ACID AND (2R)-4-(6-CHLOROPYRIDAZIN-3-YL)-N-(4-METHOXYBENZYL)-1-{[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}PIPERAZINE-2-CARBOXAMIDE
3QGG	B:3-514; B:3-514	CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE COMPLEX WITH (2E)-3-(4-{[(1-{[(13-CYCLOHEXYL-6-OXO-6,7-DIHYDRO-5H-INDOLO[1,2-D][1,4]BENZODIAZEPIN-10-YL) CARBONYL]AMINO}CYCLOPENTYL)CARBONYL]AMINO}PHENYL)PROP-2-ENOIC ACID AND N-CYCLOPROPYL-6-[(3R)-3-{[4-(TRIFLUOROMETHOXY)BENZYL]CARBAMOYL}-4-{[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}PIPERAZIN-1-YL]PYRIDAZINE-3-CARBOXAMIDE

Hepatitis C virus genotype 1b (strain HC-J4) (HCV) (8)

1NB4	B:3-514; B:3-514	HC-J4 RNA POLYMERASE APO-FORM
1NB6	B:3-514; B:3-514	HC-J4 RNA POLYMERASE COMPLEXED WITH UTP
1NB7	B:3-514; B:3-514	HC-J4 RNA POLYMERASE COMPLEXED WITH SHORT RNA TEMPLATE STRAND
2XHU	B:3-514; B:3-514	HCV-J4 NS5B POLYMERASE ORTHORHOMBIC CRYSTAL FORM
2XHV	B:3-514; B:3-514	HCV-J4 NS5B POLYMERASE POINT MUTANT ORTHORHOMBIC CRYSTAL FORM
2XHW	A:3-514	HCV-J4 NS5B POLYMERASE TRIGONAL CRYSTAL FORM
3MWV	B:3-514; B:3-514	CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE
3MWW	B:3-514; B:3-514	CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE

Hepatitis C virus genotype 2a (isolate HC-J6) (HCV) (5)

1YUY	A:3-514	HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE GENOTYPE 2A
1YV2	A:3-514	HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE GENOTYPE 2A
1YVX	A:3-514	HEPATITIS C VIRUS RNA POLYMERASE GENOTYPE 2A IN COMPLEX WITH NON- NUCLEOSIDE ANALOGUE INHIBITOR
1YVZ	A:3-514	HEPATITIS C VIRUS RNA POLYMERASE GENOTYPE 2A IN COMPLEX WITH NON- NUCLEOSIDE ANALOGUE INHIBITOR
2XWH	A:3-514	HCV-J6 NS5B POLYMERASE STRUCTURE AT 1.8 ANGSTROM

Hepatitis C virus genotype 2a (isolate JFH-1) (HCV) (2)

2XXD	A:3-514	HCV-JFH1 NS5B POLYMERASE STRUCTURE AT 1.9 ANGSTROM
2XYM	A:3-514	HCV-JFH1 NS5B T385A MUTANT

Hepatitis C virus subtype 1b (1)

2QE5

D:3-514; D:3-514; D:3-514; D:3-514

STRUCTURE OF HCV NS5B BOUND TO AN ANTHRANILIC ACID INHIBITOR

Family: RdRP_4 (7)

Rotavirus A (strain SA11-Patton G3-Px[x]-Ix-Rx-Cx-Mx-Ax-Nx-Tx-Ex-Hx) (RV-A) (Simian Agent 11 (strain (7)

2R7R	A:25-748	CRYSTAL STRUCTURE OF ROTAVIRUS SA11 VP1/RNA (UGUGACC) COMPLEX
2R7S	A:25-748	CRYSTAL STRUCTURE OF ROTAVIRUS SA11 VP1 / RNA (UGUGCC) COMPLEX
2R7T	A:25-748	CRYSTAL STRUCTURE OF ROTAVIRUS SA11 VP1/RNA (UGUGAACC) COMPLEX
2R7U	A:25-748	CRYSTAL STRUCTURE OF ROTAVIRUS SA11 VP1/RNA (AAAAGCC) COMPLEX
2R7V	A:25-748	CRYSTAL STRUCTURE OF ROTAVIRUS SA11 VP1/RNA (GGCUUU) COMPLEX
2R7W	A:25-748	CRYSTAL STRUCTURE OF ROTAVIRUS SA11 VP1/RNA (UGUGACC)/MRNA 5'-CAP (M7GPPPG) COMPLEX
2R7X	B:25-748; B:25-748	CRYSTAL STRUCTURE OF ROTAVIRUS SA11 VP1/RNA (UGUGACC)/GTP COMPLEX

Full view: branches of nodes matching the query are shown completely (Compact view)